enVVeno Medical (NVNO) Total Non-Current Liabilities (2017)
enVVeno Medical's (NVNO) quarterly Total Non-Current Liabilities came in at $8.2 million in Q4 2017.
enVVeno Medical (NVNO) Total Non-Current Liabilities (2017) Analysis & Trends
enVVeno Medical's Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $8.2 million for Q4 2017.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $8.2 million in Q4 2017; TTM through Dec 2017 was $8.2 million, a N/A change from a year earlier, with the FY2017 full-year figure at $8.2 million, changed N/A from the prior year.
- Total Non-Current Liabilities steadied at $8.2 million in Q4 2017 per NVNO's latest filing.
- Across five years, Total Non-Current Liabilities topped out at $8.2 million in Q4 2017 and bottomed at $8.2 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 8.15 Mn |